F10 and breast carcinoma: We repeated the prothrombinase assay, omitting the addition of platelet agonists convulxin and thrombin, using microparticles isolated from MDA-MB-231 human breast cancer cells as well as with similarly sized extruded synthetic liposomes containing PS (Supplementary information, Fig. S2A and B).